D

Deciphera Pharmaceuticals Inc
F:D05

Watchlist Manager
Deciphera Pharmaceuticals Inc
F:D05
Watchlist
Price: 53.93 EUR -0.09% Market Closed
Market Cap: 4.4B EUR

Relative Value

There is not enough data to reliably calculate the relative value of D05.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

D05 Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
11.9
Median 5Y
18.2
Industry
7.8
vs History
vs Industry
Median 3Y
-11
Median 5Y
-7
Industry
24.1
vs History
vs Industry
Median 3Y
-13.7
Median 5Y
-8.8
Industry
21.8
vs History
vs Industry
Median 3Y
-13.7
Median 5Y
-8.5
Industry
23.8
vs History
vs Industry
Median 3Y
6.6
Median 5Y
4
Industry
3.3
vs History
vs Industry
Median 3Y
10.4
Median 5Y
16.4
Industry
8
vs History
vs Industry
Median 3Y
10.7
Median 5Y
16.7
Industry
10.3
vs History
vs Industry
Median 3Y
-8.9
Median 5Y
-5.6
Industry
6.3
vs History
vs Industry
Median 3Y
-8.8
Median 5Y
-5.5
Industry
6.7
vs History
vs Industry
Median 3Y
-12
Median 5Y
-7.1
Industry
7.9
vs History
vs Industry
Median 3Y
-11.9
Median 5Y
-6.9
Industry
6.3
vs History
vs Industry
Median 3Y
14.1
Median 5Y
12.4
Industry
5.5

Multiples Across Competitors

D05 Competitors Multiples
Deciphera Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Deciphera Pharmaceuticals Inc
F:D05
4.4B EUR 29.7 -27.3 -24 -23.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 873 393.2 -160 995.2 -195 499.5 -193 268.7
US
Abbvie Inc
NYSE:ABBV
400.9B USD 6.7 170.7 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
176.1B USD 4.9 25.1 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
154.4B USD 5.3 19 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 9.9 31.5 23.1 24.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 079.8 -530.7 -577.9 -562.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.9B USD 5.7 17.7 16.8 19.1
AU
CSL Ltd
ASX:CSL
84.8B AUD 3.6 18.7 12.6 15.7
NL
argenx SE
XBRU:ARGX
45B EUR 14.6 34.4 59.4 61
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.7B USD 16.4 1 210.8 159.1 192.9
P/E Multiple
Earnings Growth PEG
US
D
Deciphera Pharmaceuticals Inc
F:D05
Average P/E: 191
Negative Multiple: -27.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 995.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -530.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
9%
2
AU
CSL Ltd
ASX:CSL
18.7
11%
1.7
NL
argenx SE
XBRU:ARGX
34.4
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 210.8
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
D
Deciphera Pharmaceuticals Inc
F:D05
Average EV/EBITDA: 39.8
Negative Multiple: -24
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 499.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -577.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
NL
argenx SE
XBRU:ARGX
59.4
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
159.1
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
D
Deciphera Pharmaceuticals Inc
F:D05
Average EV/EBIT: 45.9
Negative Multiple: -23.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 268.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -562.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.1
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
NL
argenx SE
XBRU:ARGX
61
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
192.9
N/A N/A